NCT02237079View on ClinicalTrials.gov

Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
ObesityGlucose HomeostasisPostmenopausal Symptoms
Interventions
DRUG

Bazedoxifene/Conjugated Estrogens (BZA/CE)

Daily tablet containing conjugated estrogens 0.45 mg and bazedoxifene 20 mg.

DRUG

Placebo Oral Tablet

Daily placebo tablet

Trial Locations (1)

70112

Tulane University Clinical Translational Unit, New Orleans

All Listed Sponsors
lead

Tulane University Health Sciences Center

OTHER

NCT02237079 - Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM) | Biotech Hunter | Biotech Hunter